Ilika targets commercial traction through Brompton e-bike battery programme

Ilika Plc

Ilika has moved its solid-state battery technology into a more commercially relevant stage with a £214,000 development programme alongside Brompton Bicycles. The 12-month project will test Ilika’s 10Ah Goliath batteries in packs for Brompton’s next generation of electric folding bikes, with battery pack production and bike trials planned for mid-2027 if development targets are met.

This is not a large contract, but it is a practical test of whether Ilika’s technology can perform in a real product with a recognised manufacturer. That matters because battery companies need more than technical promise. They need proof that customers can use the product in applications where performance, safety and design constraints all matter.

Folding e-bikes are highly sensitive to battery size, weight and safety, so they provide a useful test case for Goliath. If Ilika’s cells can help reduce weight while maintaining safety and energy performance, that strengthens the company’s case in mobility markets where those factors directly affect product appeal and regulatory acceptance.

Concerns around battery fires have become harder to ignore across the e-bike market, creating a clearer commercial opening for technologies that can offer a safer alternative. Ilika is using this programme to show that solid-state batteries are not simply an improvement in theory, but a possible answer to a visible market problem.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search